Table 4.
Descriptive statistics of people living with HIV, preexposure prophylaxis (PrEP) users, postexposure prophylaxis (PEP) users, and people not living with HIV cohorts.
| Characteristics | People living with HIV (n=132,664; confidence level 1-2) | People living with HIV (n=152,282; confidence level 1-3) | PrEP users (n=36,088) | PEP users (n=4120)a | People not living with HIV (n=20,639,675) | |
| Race or ethnicity, n (%) | ||||||
|
|
Hispanic or Latinx, any race | 20,925 (15.8) | 23,346 (15.3) | 5829 (16.2) | 403 (9.8) | 2,628,308 (12.7) |
|
|
Non-Hispanic American Indian or Alaska Native | 615 (0.5) | 684 (0.4) | 163 (0.5) | <20 (0.5) | 85,524 (0.4) |
|
|
Non-Hispanic Asian | 2753 (2.1) | 3517 (2.3) | 1726 (4.8) | 222 (5.4) | 729,491 (3.5) |
|
|
Non-Hispanic Black or African American | 49,769 (37.5) | 55,144 (36.2) | 4534 (12.6) | 784 (19) | 2,909,443 (14.1) |
|
|
Non-Hispanic combinedb | 903 (0.7) | 1150 (0.8) | 505 (1.4) | 40 (1) | 281,450 (1.4) |
|
|
Non-Hispanic Native Hawaiian or Pacific Islander | 247 (0.2) | 300 (0.2) | 88 (0.2) | <20 (0.5) | 67,808 (0.3) |
|
|
Non-Hispanic White | 48,604 (36.6) | 57,479 (37.7) | 19,663 (54.5) | 2119 (51.4) | 11,966,553 (58) |
|
|
Unknown | 8848 (6.7) | 10,662 (7) | 3580 (9.9) | 512 (12.4) | 1,971,098 (9.6) |
| Age (y), median (IQR) | 51 (38-61) | 51 (37-61) | 36 (30-46) | 35 (28-44) | 44 (26-63) | |
| Sex, n (%) | ||||||
|
|
Female | 42,093 (31.7) | 49,846 (32.7) | 4253 (11.8) | 2693 (65.4) | 11,579,223 (56.1) |
|
|
Male | 90,496 (68.2) | 102,332 (67.2) | 31,722 (87.9) | 1399 (34) | 9,044,853 (43.8) |
|
|
Combined or unknownc | 75 (0.1) | 104 (0.1) | 113 (0.3) | <20 (0.5) | 15,599 (0.1) |
| Comorbidity, n (%) | ||||||
|
|
Myocardial infarction | 9265 (7) | 10,349 (6.8) | 482 (1.3) | 57 (1.4) | 795,829 (3.9) |
|
|
Congestive heart failure | 10,926 (8.2) | 12,106 (7.9) | 406 (1.1) | 42 (1) | 998,313 (4.8) |
|
|
Peripheral vascular disease | 8002 (6) | 8971 (5.9) | 352 (1) | 52 (1.3) | 787,932 (3.8) |
|
|
Cerebrovascular disease | 9082 (6.8) | 10,123 (6.6) | 492 (1.4) | 76 (1.9) | 977,070 (4.7) |
|
|
Dementia | 3177 (2.4) | 3638 (2.4) | 225 (0.6) | 63 (1.5) | 475,742 (2.3) |
|
|
Chronic lung disease | 40,080 (30.2) | 44,328 (29.1) | 5617 (15.6) | 716 (17.5) | 3,562,138 (17.3) |
|
|
Rheumatologic disease | 10,245 (7.7) | 11,502 (7.6) | 1280 (3.5) | 139 (3.4) | 1,097,753 (5.3) |
|
|
Peptic ulcer | 4445 (3.4) | 4919 (3.2) | 466 (1.3) | 61 (1.5) | 335,672 (1.6) |
|
|
Liver disease | 32,690 (24.6) | 35,536 (23.3) | 2965 (8.2) | 320 (7.8) | 1,314,849 (6.4) |
|
|
Diabetes | 28,307 (21.3) | 31,731 (20.8) | 2631 (7.3) | 321 (7.8) | 2,750,693 (13.3) |
|
|
Hemiplegia or paraplegia | 3751 (2.8) | 4124 (2.7) | 121 (0.3) | 32 (0.8) | 281,201 (1.4) |
|
|
Kidney disease | 26,015 (19.6) | 28,288 (18.6) | 1142 (3.2) | 157 (3.8) | 1,681,615 (8.1) |
|
|
Cancer | 20,035 (15.1) | 22,447 (14.7) | 1399 (3.9) | 143 (3.5) | 1,866,452 (9) |
|
|
Hypertension | 63,025 (47.5) | 69,487 (45.6) | 7464 (20.7) | 691 (16.9) | 5,904,993 (28.6) |
|
|
Tobacco smoking | 34,189 (25.8) | 37,120 (24.4) | 5830 (16.2) | 550 (13.4) | 1,844,538 (8.9) |
| BMI, n (%) | ||||||
|
|
Underweight | 2280 (1.7) | 2931 (1.9) | 378 (1) | 90 (2.2) | 1,156,445 (5.6) |
|
|
Healthy weight | 20,789 (15.7) | 23,743 (15.6) | 6684 (18.5) | 710 (17.3) | 2,837,262 (13.7) |
|
|
Overweight | 35,471 (26.7) | 39,718 (26.1) | 10,600 (29.4) | 864 (21.1) | 3,565,102 (17.3) |
|
|
Obese | 52,872 (39.9) | 59,238 (38.9) | 12,240 (33.9) | 1369 (33.4) | 6,260,259 (30.3) |
|
|
Missing | 21,252 (16) | 26,652 (17.5) | 6186 (17.1) | 1066 (26) | 6,820,607 (33) |
aThe PEP cohort is estimated to obfuscate any groups with counts <20 to follow National Clinical Cohort Collaborative governance rules. This will also cause percentages not to sum to 100 in this group.
bIncludes individuals with race and ethnicity variable values that do not include Hispanic, White, Black or African American, Asian, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander.
cIncludes individuals with sex variable values that do not include male or female.